regeneron dna - Search News

Order byBest matchMost fresh

Regeneron Pharmaceuticals to buy 23andMe and its data

23andMe sells its most valuable asset. Regeneron promises keep your DNA private.

Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Holding Co.

· 23h · on MSN

· 16h · on MSN

Now we know who's getting 23andMe's DNA data. Meet Regeneron Pharmaceuticals.

· 56m · on MSN

Pharmaceutical company Regeneron buying 23andMe for $256 million

23andMe Sold To Biotechnology Company For $256 Million

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

· 17h

· 19h

Regeneron agrees to buy bankrupt 23andMe

· 1d

Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million

A drug developer is buying 23andMe - what does that mean for your DNA data?

Regeneron vows to prioritize the privacy, security, and ethical use of customer data.

· 18h

· 19h

23andMe bought by Regeneron in court auction

· 22h

Biotechnology Company Regeneron to Buy 23andMe for $256 million

20h

Biotech company Regeneron to buy bankrupt 23andMe for $256M

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy protection promises.

Stocktwits on MSN1d

Regeneron To Buy Assets Of 23andMe For $256M: Retail Says ‘Fantastic’ For Future R&D Efforts

Drugmaker Regeneron Pharmaceuticals, Inc. (REGN) said on Monday that it will acquire the assets of bankrupt biotechnology company 23andMe Holding Co. for $256 million. Regeneron intends to acquire 23andMe’s Personal Genome Service (PGS),